Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali I Al-Gareeb

Showing results (71-80 of 292) with videos related to

Pageof 30
Sort By:
Inflammopharmacology|August 3, 2022
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspectiveHayder M Al-Kuraishy, Ali I Al-Gareeb, Walaa A Negm, et al.
Frontiers in Medicine|March 15, 2021
COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of MetforminHayder M Al-Kuraishy, Ali I Al-Gareeb, M Alblihed, et al.
Inflammopharmacology|March 24, 2023
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effectsMohammed Alrouji, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Autophagy|June 14, 2024
Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetesHayder M Al-Kuraishy, Majid S Jabir, Ali I Al-Gareeb, et al.
Neurological Research|March 5, 2026
The potential role of metformin in multiple sclerosis: good or bad, and what's the lessonAli Abdullah AlAseeri, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Frontiers in Pharmacology|May 10, 2021
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging PerspectivesHayder M Al-Kuraishy, Ali I Al-Gareeb, Mohammed Alqarni, et al.
Chemistry & Biodiversity|April 1, 2025
Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless ConditionAli I Al-Gareeb, Morkoss Fakhry, Ali K Albuhadily, et al.
Neurology India|January 4, 2022
Statins Therapy Improves Acute Ischemic Stroke in Patients with Cardio-metabolic Disorders Measured by Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): New Focal PointHayder M Al-Kuraishy, Nawar R Hussien, Marwa S Al-Naimi, et al.
Scientific African|October 31, 2022
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquerGaber El-Saber Batiha, Ali I Al-Gareeb, Damilare Rotimi, et al.
Inflammopharmacology|April 26, 2022
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisonsHayder M Al-Kuraishy, Ali I Al-Gareeb, Luay Alkazmi, et al.
Pageof 30

Showing results (71-80 of 292) with videos related to

Sort By:
Pageof 30
Inflammopharmacology|August 3, 2022
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspectiveHayder M Al-Kuraishy, Ali I Al-Gareeb, Walaa A Negm, et al.
Frontiers in Medicine|March 15, 2021
COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of MetforminHayder M Al-Kuraishy, Ali I Al-Gareeb, M Alblihed, et al.
Inflammopharmacology|March 24, 2023
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effectsMohammed Alrouji, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Autophagy|June 14, 2024
Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetesHayder M Al-Kuraishy, Majid S Jabir, Ali I Al-Gareeb, et al.
Neurological Research|March 5, 2026
The potential role of metformin in multiple sclerosis: good or bad, and what's the lessonAli Abdullah AlAseeri, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Frontiers in Pharmacology|May 10, 2021
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging PerspectivesHayder M Al-Kuraishy, Ali I Al-Gareeb, Mohammed Alqarni, et al.
Chemistry & Biodiversity|April 1, 2025
Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless ConditionAli I Al-Gareeb, Morkoss Fakhry, Ali K Albuhadily, et al.
Neurology India|January 4, 2022
Statins Therapy Improves Acute Ischemic Stroke in Patients with Cardio-metabolic Disorders Measured by Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): New Focal PointHayder M Al-Kuraishy, Nawar R Hussien, Marwa S Al-Naimi, et al.
Scientific African|October 31, 2022
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquerGaber El-Saber Batiha, Ali I Al-Gareeb, Damilare Rotimi, et al.
Inflammopharmacology|April 26, 2022
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisonsHayder M Al-Kuraishy, Ali I Al-Gareeb, Luay Alkazmi, et al.
Pageof 30